Company Also Announces Completion of Mammalian Cell Process Development Capacity Expansion TUSTIN, Calif., April 04, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated ...
Completion of CGT Facility Brings Company’s Total Revenue Generating Capacity to up to Approximately $400 Million Annually TUSTIN, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices (CDMO), ...
Avid in 2023 opened its $75M, 53K-sq-ft. manufacturing facility in Costa Mesa Avid Bioservices Inc. in the last seven years has transformed from a struggling clinical developer of cancer drugs to a ...
As AGC Biologics looks to recalibrate its CDMO business, the Seattle-based manufacturer is planning to part ways with a pair of facilities in Colorado. AGC has started a “structured process” to seek ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results